Catalog No.
Product Name
Application
Product Information
Citations
-
Anti-Bacterial Agent
Lunatoic acid A functions as an anti-bacterial agent with notable effects against specific bacterial strains. In addition to its antibacterial properties, this compound also exhibits partial anti-mould activity. It is applicable in research focused on microbial inhibition and the development of antimicrobial therapies. -
Anti-Bacterial Agent
γ-Chloronorvaline is an anti-bacterial agent that exhibits resistance against Pseudomonas aeruginosa, Serratia, Klebsiella pneumoniae, and Bacillus subtilis in synthetic media. This compound is particularly useful in research applications focused on combating infections caused by these specific pathogens. Notably, it shows no activity against Escherichia coli, making it a selective agent for targeted bacterial strains. -
Anti-Bacterial Agent
3-epi-Deoxynegamycin is an antibacterial agent that primarily targets Gram-positive bacteria. It exhibits significant antibacterial activity against a wide range of Gram-positive strains, while displaying limited efficacy against Gram-negative bacteria. This compound is valuable for research applications focused on understanding bacterial resistance and developing new therapeutic strategies against bacterial infections. -
Antibacterial Agent
PGE 9262932 is a quinolone antibacterial agent that targets bacterial DNA gyrase and topoisomerase IV, disrupting core processes of bacterial replication. This compound exhibits significant antibacterial activity, making it suitable for research applications focused on infections caused by a variety of bacterial pathogens. It serves as a valuable tool in the study of bacterial resistance mechanisms and the development of novel antimicrobial therapies. -
Bacterial Inhibitor
3-Fluoro-DL-valine is an unnatural amino acid that functions as a bacterial inhibitor by disrupting protein synthesis in targeted bacterial strains. This compound demonstrates significant antibacterial activity, making it a valuable tool in microbiological studies. Additionally, 3-Fluoro-DL-valine can be utilized in peptide synthesis, offering versatile applications for the development of bioactive peptides in biochemical research and drug discovery. Its distinct structural properties position it as a promising candidate for innovative compound research and development. -
Antibacterial Agent
Dapabutan is an antimicrobial agent primarily targeting Gram-positive bacteria. It exhibits potent antibacterial activity, making it suitable for research focused on the development of novel treatments for bacterial infections. Its mechanism of action involves disrupting bacterial cell wall synthesis, thereby inhibiting growth and proliferation. This compound is valuable for studies in microbiology and pharmaceutical development. -
Anti-Bacterial Agent
Pyloricidin A is an antibiotic that specifically targets Helicobacter pylori, derived from Bacillus sp. HC-70. It exhibits potent anti-H. pylori activity, making it a valuable reagent for studying this pathogen. Pyloricidin A is selective and shows no activity against other bacterial strains or yeast, providing a focused approach for research applications related to H. pylori infections. -
Anti-Bacterial Agent
Dihydrogranaticin is an anti-bacterial agent targeting Bacillus cereus. It exhibits significant antimicrobial activity, making it a valuable tool in the study and development of treatments against bacterial infections. This compound is suitable for research applications focused on antimicrobial resistance and the efficacy of new antibacterial therapies. -
Anti-Bacterial Agent
Coumermycin A2 is an anti-bacterial agent that primarily targets Gram-positive bacteria, displaying weak activity against mycobacterium. This compound has significant applications in research focused on bacterial resistance and the development of novel antibacterial therapies. Its mechanism of action involves inhibition of bacterial growth, providing a valuable tool for studies in microbiology and drug discovery. -
Antibacterial Agent
KY-9 is an antibacterial agent that functions by inhibiting bacterial growth through its targeted mechanism of action. This compound exhibits notable efficacy against a range of Gram-positive and Gram-negative bacteria. As a result, KY-9 serves as a valuable tool in microbiological research and the development of antimicrobial therapies. -
Bacterial
Flambalactone is a degradation product derived from the methanolysis of the antibiotic flambamycin. It targets bacterial systems and exhibits inhibitory activity against various strains of pathogenic bacteria. This compound is useful in research applications focused on understanding antibiotic resistance mechanisms and bacterial cell viability. -
Antibacterial Agent
LB 10517 (sodium) is a cephalosporin antibiotic known for its broad-spectrum antibacterial activity. It effectively targets both Gram-positive and Gram-negative bacteria, including notable pathogens such as Enterobacteriaceae, Pseudomonas aeruginosa, Staphylococcus, and Streptococcus. This compound is valuable for research applications focused on bacterial infections and antibiotic resistance mechanisms. -
Anti-Bacterial Agent
9-Hydroxycrisamicin, an anti-bacterial agent, exhibits weak activity against Gram-positive bacteria with a minimum inhibitory concentration (MIC) ranging from 6.25 to 25 μg/mL. Additionally, 9-Hydroxycrisamicin demonstrates significant growth inhibition in various human tumor cell lines, making it a valuable compound for research in both antibacterial and oncological studies. -
Anti-Bacterial Agent
Kigamicin A is an anti-bacterial agent with demonstrated efficacy against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Its minimum inhibitory concentrations (MICs) range from 0.025 to 0.78 μg/mL, indicating potent antibacterial activity. This compound is valuable in research focused on combating antibiotic-resistant bacterial infections and exploring new therapeutic options. -
Antibacterial Agent
PYO12 is a selective antibacterial compound targeting Gram-positive bacteria. It demonstrates potent activity against S. aureus, B. subtilis, S. pneumoniae, and MRSA, with minimum inhibitory concentrations (MIC) of 1 μg/mL for the first three and 4 μg/mL for MRSA. PYO12 enhances bacterial membrane permeability and upregulates stress-related genes by potentially binding to the C55-PP moiety of lipid II. Its concentration-dependent bactericidal effect, coupled with low toxicity to mammalian cells and lack of hemolytic activity, positions PYO12 as a promising candidate for the development of novel antibiotics focused on bacterial cell wall synthesis. -
Antibacterial Agent
ML370 is an antibacterial agent that functions by inhibiting the activity of the Vibrio cholerae LuxO kinase. This inhibition disrupts bacterial signaling, thereby impeding the growth and virulence of cholera pathogens. ML370 is suitable for research applications focused on infectious diseases, particularly in studies related to cholera and other Vibrio species. -
Anti-Bacterial Agent
Emerimicin III is an anti-bacterial agent primarily targeted against Gram-positive bacteria. This compound exhibits potent inhibitory effects, making it a valuable tool in research focused on bacterial infections and resistance mechanisms. Its unique structure and activity profile facilitate studies into novel therapeutic approaches for combatting Gram-positive pathogens. -
Anti-Bacterial Agent
Hazimycin 5 is an anti-bacterial agent with demonstrated activity against Gram-negative bacteria, as well as select yeast and skin fungi. This compound is useful in research applications focused on identifying and characterizing the mechanisms of bacterial resistance and the effects of antimicrobial agents. Its weak activity profile makes it particularly relevant in studies exploring the efficacy of combination therapies or the development of new antimicrobial compounds. -
Antibacterial Agent
Antibacterial agent 311 targets bacterial infections through its potent antibacterial activity. It demonstrates efficacy against clinically relevant pathogens, including Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and resistant strains such as E. CTXM1 and E. NDM1, with minimal inhibitory concentrations (MICs) ranging from 0.7 to 1 mg/mL. This compound is valuable for research applications focused on antimicrobial resistance and the development of novel antibacterial therapies. -
Anti-Bacterial Agent
Curvulic acid is an anti-bacterial agent that exhibits modest inhibitory activity against both Gram-positive and Gram-negative bacteria. Its biological activity makes it a potential candidate for research in antimicrobial studies and the development of new antibacterial therapies. This compound can be utilized in investigations focusing on bacterial resistance mechanisms and the evaluation of novel antibacterial agents. -
Bacterial Inhibitor
WQ3810 is a fluoroquinolone antibiotic that acts by inhibiting bacterial DNA gyrase and topoisomerase IV, critical enzymes for DNA replication and transcription. This compound exhibits potent antibacterial activity against a range of gram-positive and gram-negative bacteria. WQ3810 is valuable for research applications focused on studying bacterial infections and developing effective antimicrobial therapies. -
Bacterial Inhibitor
Vebufloxacin is a synthetic antibacterial agent that targets bacterial DNA gyrase, leading to the inhibition of bacterial DNA replication and transcription. It demonstrates potent activity against both gram-positive and gram-negative bacteria, making it a valuable tool in studying bacterial infections and resistance mechanisms. Research applications include evaluating the efficacy of antibacterial treatments and understanding the molecular basis of bacterial survival. -
Bacterial Inhibitor
BO3482 is a bacterial inhibitor that exhibits antimicrobial activity against methicillin-resistant Staphylococci (MRS). It demonstrates a minimum inhibitory concentration (MIC90) of 6.25 mg/mL, effectively halting bacterial growth. This compound is valuable for research applications focused on antibiotic resistance and the development of new antibacterial agents. -
Bacterial Inhibitor
A7132 is a potent antibacterial agent that targets bacterial infections. This compound exhibits broad-spectrum antibacterial activity, making it a valuable tool for research applications in antimicrobial studies and the development of new therapies against bacterial resistance. A7132 is suitable for evaluating the efficacy of antibacterial compounds in various biological assays. -
Non-Antibacterial Macrolide Agent
Glasmacinal is a non-antibacterial macrolide agent that primarily targets inflammatory pathways. It exhibits significant anti-inflammatory activity, making it a valuable tool for researchers studying inflammation-related processes. This compound can be utilized in various biological research applications, including the exploration of immune response modulation and the development of novel therapeutic strategies. -
Antibacterial Agent
HSGN-218 is an antibacterial agent that demonstrates potent efficacy against various strains of Clostridium difficile, exhibiting minimum inhibitory concentration (MIC) values between 0.007 μM and 0.07 μM. Despite its low permeability across Caco-2 cells, HSGN-218 is a valuable tool for investigating bacterial growth inhibition and exploring therapeutic options for C. difficile infections in research applications. -
Bacterial Inhibitor
Pyrroxamycin is a novel antibiotic with a primary mechanism targeting Gram-positive bacteria and dermatophytes. Derived from the fermentation of Streptomyces, it exhibits potent antibacterial activity. This compound has potential applications in pharmaceutical research for the development of new antimicrobials, particularly against resistant bacterial strains. Detailed analysis of its chemical structure was performed using X-ray crystallography and 13C NMR spectroscopy, elucidating its physicochemical properties and enhancing its utility in microbiological studies. -
Antibacterial Agent
Antibacterial Agent 39 is a potent antibacterial compound that demonstrates synergistic effects by significantly lowering the minimum inhibitory concentration (MIC) of Ceftazidime. This compound exhibits strong antibacterial activity against various Gram-negative bacteria, making it a valuable tool for research focused on combating antibiotic resistance and enhancing the efficacy of existing antibiotics. Its application in microbiological studies can provide insights into the mechanisms of action and interactions between different antibacterial agents. -
Anti-Bacterial Agent
Juncuenin D is an anti-bacterial agent known for its ability to induce caspase-3-mediated cytotoxicity in HT22 cells. This compound exhibits significant anti-bacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) strains. Juncuenin D is derived from Juncus effusus and serves as a valuable tool for research in infectious disease and cell death mechanisms. -
Antibacterial Peptide
Latarcin 2a is a linear cationic antibacterial peptide derived from the venom of the spider Lachesana tarabaevi, exhibiting broad-spectrum antibacterial activity. It demonstrates a minimum inhibitory concentration (MIC) of 0.5 μM against both Bacillus subtilis and Escherichia coli. This peptide is primarily utilized in research related to infectious diseases and the development of novel antimicrobial agents. -
Antibacterial Agent
Antibacterial Agent 60 is a potent antibacterial compound that enhances the efficacy of Ceftazidime by significantly reducing its minimum inhibitory concentration (MIC). This agent exhibits strong antibacterial activity, making it particularly useful in overcoming bacterial resistance. It can be employed in various research applications focused on developing improved antimicrobial therapies and optimizing existing antibiotics against resistant strains. -
Bacterial Inhibitor
β-Lactamase-IN-6 is a potent inhibitor of β-Lactamase enzymes, which play a crucial role in bacterial resistance to β-lactam antibiotics. This compound demonstrates significant antibacterial activity by preventing the enzymatic breakdown of β-lactam antibiotics, thereby enhancing their effectiveness against resistant bacterial strains. β-Lactamase-IN-6 serves as a valuable tool in microbiological research and antibiotic development, providing insights into combating bacterial infections and resistance mechanisms. -
Antibacterial Agent
Antibacterial Agent 51 primarily targets bacterial cell growth and division. It exhibits minimum inhibitory concentration (MIC) values of 4 mcg/mL against E. coli NCTC 13351 and 8 mcg/mL against both E. coli strains M 50 and 7 MP. This compound is valuable for research applications focused on bacterial resistance and the development of new antibacterial therapies. -
Bacterial Inhibitor
(R)-Gyramide A hydrochloride is a bacterial DNA gyrase inhibitor that effectively disrupts DNA supercoiling, exhibiting an IC50 of 3.3 µM. This compound demonstrates significant antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Salmonella enterica, with minimum inhibitory concentrations ranging from 10 to 80 µM. Notably, (R)-Gyramide A hydrochloride does not inhibit topoisomerase IV, making it a valuable tool for studying bacterial mechanisms and antibiotic resistance. -
Antibacterial Agent
Heronapyrrole B is a Gram-positive-selective antibacterial agent with an IC50 range of 0.6-1.1 μM against Staphylococcus aureus ATCC9144. This compound demonstrates potent antibacterial activity, making it a valuable tool in the study of bacterial infections. Its specific mechanism of action and efficacy position it for potential applications in antibiotic research and development. -
Antibacterial Agent
Antibacterial Agent 192 is an antibacterial compound that targets and disrupts iron homeostasis in Escherichia coli. This mechanism leads to impaired bacterial growth and viability, making it a valuable tool for studying bacterial metabolism and resistance mechanisms. Its applications include research in antibiotic development and the investigation of bacterial iron regulation processes. -
Antimycobacterial Agent
3β,7β,15β-Trihydroxy-11-oxo-lanosta-8-en-24→20 lactone is a natural compound with noted antimycobacterial activity. Isolated from Ganoderma lucidum, this compound demonstrates effectiveness against mycobacterial infections, making it a valuable resource in antibacterial research. Its unique structure and biological properties render it a promising candidate for further investigation in the development of antimycobacterial therapies. -
Antibacterial Agent
Ro 24-4383 is a carbamate-linked compound that exhibits antibacterial activity through a dual mechanism of action. It effectively targets bacterial cell processes, making it a valuable tool in antibacterial research. This compound is useful for studies related to bacterial resistance and the development of new antibacterial therapies. -
Bacterial
B1912 is an antibacterial compound that demonstrates significant efficacy against various bacterial strains. Its primary mechanism involves disrupting bacterial cell wall synthesis, leading to cell lysis and death. This reagent is valuable for research applications focused on developing new antibacterial therapies and studying bacterial resistance mechanisms. -
Antibacterial Agent
DPI-2016 is an antibacterial agent that demonstrates potent bactericidal activity, with minimum inhibitory concentrations (MIC) ranging from 0.25 to 8 μg/mL across various bacterial strains. This compound exhibits enhanced effectiveness compared to standard treatments such as aztreonam, which has MIC values between 16 and greater than 64 μg/mL. DPI-2016 is suitable for research applications aimed at investigating bacterial resistance and efficacy in therapeutic interventions. -
Antibacterial Agent
Bauer-7-ene-3β,16α-diol is a triterpenoid with demonstrated antibacterial properties, primarily targeting bacterial strains such as E. coli. Isolated from the dried flower buds of Tussilago farfara L. or Petasites tricholobus, it exhibits medium antibacterial activity, making it a valuable reagent for research in natural product pharmacology and the development of antimicrobial agents. Its structural features and potency may facilitate investigations into the mechanisms of bacterial resistance and alternative therapeutic strategies. -
Antibacterial Agent
Antibacterial agent 99 (compound 7b) is a potent antibacterial compound that targets bacterial cell wall synthesis. It exhibits significant antibacterial and antifungal activity, making it suitable for various microbiological research applications. Additionally, antibacterial agent 99 demonstrates no hemolytic activity, indicating a favorable safety profile for potential therapeutic use. -
Bacterial Inhibitor
Acrisorcin is a topical anti-infective compound that functions primarily as a bacterial inhibitor. It exhibits potent fungicidal properties, making it valuable for research into antifungal therapies and the understanding of bacterial resistance mechanisms. Its efficacy in mitigating fungal infections supports its application in various microbiological studies and therapeutic evaluations. -
Antibacterial Agent
Antibacterial Agent 45 is an effective antibacterial compound that enhances the efficacy of Ceftazidime by significantly lowering its minimum inhibitory concentration (MIC) value. This agent demonstrates potent antibacterial activity, making it a valuable tool for researchers studying bacterial resistance and developing novel antimicrobial therapies. Its application in combinatorial therapies holds promise for advancing understanding of bacterial pathogenesis and treatment strategies. -
Antibacterial Agent
Prenylterphenyllin is an antibacterial agent derived from the marine fungus Aspergillus candidus IF10. It exhibits significant cytotoxic activity against KB3-1 cells, with an IC50 value of 8.5 mg/mL. Additionally, Prenylterphenyllin demonstrates antibacterial properties against Xanthomonas oryzae and Erwinia amylovora, both exhibiting minimum inhibitory concentrations (MICs) of 20 μg/mL. This compound is useful for research in antimicrobial drug development and the study of marine-derived natural products. -
Antibacterial agent
Antibacterial Agent 245 (Dc-2) is an effective antibacterial compound targeting plant pathogenic fungi and bacteria. It demonstrates a potent activity with an EC50 value of 1.29 μg/mL against Botrytis cinerea. This reagent is suitable for research applications in plant pathology and the development of biocontrol agents. -
Anti-Bacterial Agent
Galacardin A is an anti-bacterial agent that primarily exhibits activity against Gram-positive bacteria. Its mechanism of action involves disrupting bacterial cell wall synthesis, resulting in inhibition of bacterial growth. Galacardin A is suitable for research applications focused on developing new antibacterial therapies and studying microbial resistance. -
Anti-Bacterial Agent
Polymyxin S1 is an anti-bacterial agent derived from Bacillus polymyxa RS-6, known for its potent activity against Gram-negative bacteria. This compound disrupts bacterial cell membrane integrity, leading to cell lysis and death. Polymyxin S1 is primarily utilized in research focusing on antibiotic action mechanisms and the development of new antimicrobial strategies. It offers valuable insights for studies targeting drug resistance and the efficacy of antibacterial compounds. -
Anti-Bacterial Agent
Pacidamycin 5 is an anti-bacterial agent that exhibits inhibitory activity against Pseudomonas aeruginosa. Additionally, it demonstrates effectiveness against various strains of bacteria, including Staphylococcus aureus and Escherichia coli. This compound is valuable for research applications focused on the development of novel antibacterial therapies. -
Anti-Bacterial Agent
Cephamycin A is an antibiotic that primarily targets bacterial cell wall synthesis. It exhibits moderate antibacterial activity against a range of Gram-positive and Gram-negative bacteria. This compound is useful in research applications focused on developing novel antibacterial agents and studying bacterial resistance mechanisms.
